Acadian Asset Management
CO

Acadian Asset Management’s Global Cord Blood Corporation CO Stock Holding History

Acadian Asset Management’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,667
Closed -$110K – 2155
2021
Q2 		$110K Sell
20,667
-16,414
-44% -$85.9K ﹤0.01% 1615
2021
Q1 		$168K Buy
+37,081
New +$161K ﹤0.01% 1549
2018
Q2 		– Sell
-31,687
Closed -$323K – 1962
2018
Q1 		$323K Sell
31,687
-37,524
-54% -$383K ﹤0.01% 957
2017
Q4 		$689K Sell
69,211
-25,283
-27% -$276K ﹤0.01% 759
2017
Q3 		$1.05M Sell
94,494
-528,501
-85% -$6.19M ﹤0.01% 675
2017
Q2 		$5.9M Buy
622,995
+32,592
+6% +$260K 0.03% 364
2017
Q1 		$3.93M Buy
590,403
+18,801
+3% +$111K 0.02% 461
2016
Q4 		$3.5M Sell
571,602
-6,306
-1% -$31.4K 0.02% 475
2016
Q3 		$2.95M Sell
577,908
-135,867
-19% -$724K 0.01% 450
2016
Q2 		$4.1M Sell
713,775
-50,144
-7% -$305K 0.02% 411
2016
Q1 		$4.64M Sell
763,919
-280,903
-27% -$1.68M 0.02% 415
2015
Q4 		$6.66M Sell
1,044,822
-91,375
-8% -$577K 0.03% 348
2015
Q3 		$6.84M Sell
1,136,197
-77,504
-6% -$482K 0.04% 341
2015
Q2 		$7.48M Buy
1,213,701
+368,334
+44% +$2.26M 0.04% 334
2015
Q1 		$4.32M Sell
845,367
-21,439
-2% -$105K 0.02% 415
2014
Q4 		$3.92M Hold
866,806
– – 0.02% 439
2014
Q3 		$4.24M Buy
866,806
+174,245
+25% +$845K 0.02% 383
2014
Q2 		$3.82M Buy
692,561
+80,774
+13% +$363K 0.02% 413
2014
Q1 		$2.45M Buy
611,787
+199,685
+48% +$812K 0.01% 453
2013
Q4 		$1.65M Buy
412,102
+385,511
+1,450% +$1.54M 0.01% 507
2013
Q3 		$101K Buy
26,591
+7,623
+40% +$28.7K ﹤0.01% 810
2013
Q2 		$53K Buy
+18,968
New +$54.1K ﹤0.01% 806

Other funds holding CO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Acadian Asset Management's CO Position: Q3 2021 in Review

Acadian Asset Management sold out of Global Cord Blood Corporation (CO) in Q3 2021, closing a stake of 20,667 shares — an estimated $110K sold.

Acadian Asset Management first reported a position in CO in Q2 2013 and held it in 22 quarters. The position peaked at $7.48M in Q2 2015. 28 funds tracked by Wall St. Rank hold CO as of Q3 2021.

  • Acadian Asset Management reported no remaining Global Cord Blood Corporation position as of Q3 2021 after selling out during the quarter.
  • Acadian Asset Management sold 20,667 Global Cord Blood Corporation shares in Q3 2021, an estimated $110K.
  • Acadian Asset Management first reported a position in Global Cord Blood Corporation in Q2 2013 and held it in 22 quarters.
  • Acadian Asset Management's Global Cord Blood Corporation position peaked at $7.48M in Q2 2015.
  • 28 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2021.

Based on Acadian Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.